Pfizer share price has zoomed 4% and is presently trading at Rs 5,549.8.
Meanwhile, the BSE HEALTHCARE index is at 40,152.3 (down 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 5.3%) and GRANULES INDIA (up 4.3%).
ALEMBIC PHARMA (down 5.0%) and Torrent Pharma (down 2.4%) are among the top losers today.
Over the last one year, Pfizer has moved up from Rs 3,849.8 to Rs 5,549.8, registering a gain of Rs 1,700.1 (up 44.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,979.9 to 40,152.3, registering a gain of 48.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 101.2%), Lupin (up 97.2%) and Cadila Healthcare (up 96.3%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 81,411.0 (up 0.1%).
The top gainers among the BSE Sensex today are Tata Motors (up 3.4%) and NTPC (up 3.3%). The most traded stocks in the BSE Sensex are Tata Steel and Axis Bank.
In the meantime, NSE Nifty is at 24,840.9 . Tata Motors and NTPC are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,707.2 to 81,411.0, registering a gain of 14,703.8 points (up 22.0%).
Pfizer net profit grew 61.1% YoY to Rs 1,507 million for the quarter ended June 2024, compared to a profit of Rs 935 million a year ago. Net sales rose 5.9% to Rs 5,629 million during the period as against Rs 5,314 million in April-June 2023.
For the year ended March 2023, Pfizer reported 1.9% increase in net profit to Rs 6,239 million compared to net profit of Rs 6,126 million during FY22. Revenue of the company fell 7.1% to Rs 24,248 million during FY23.
The current Price to earnings ratio of Pfizer, based on rolling 12 month earnings, stands at 41.7.
Equitymaster requests your view! Post a comment on "Pfizer Gains 4%; BSE HEALTHCARE Index Down 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!